You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Age-Related Macular Degeneration

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neovascular Age-related Macular Degeneration Trial (RRG001)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • (no location specified)
Nov 15, 2023

Neovascular Age-related Macular Degeneration Trial in Graz (Aflibercept 40 MG/ML, Faricimab 120 MG/ML)

Recruiting
  • Neovascular Age-related Macular Degeneration
  • Aflibercept 40 MG/ML
  • Faricimab 120 MG/ML
  • Graz, Styria, Austria
    Department of Ophthalmolgy, Medical University Graz
Jul 3, 2023

Preparation of Patient Autologous Induced Pluripotent Stem

Not yet recruiting
  • Age-Related Macular Degeneration
  • somatic cell collection
  • (no location specified)
Aug 14, 2023

Neovascular Age-related Macular Degeneration Trial in Phoenix (CLS-AX, Aflibercept)

Recruiting
  • Neovascular Age-related Macular Degeneration
  • Phoenix, Arizona
    Retinal Research Institute, LLC
Jun 4, 2023

Intestinal Microbiome in Wet Age-related Macular Degeneration

Recruiting
  • Age-Related Macular Degeneration
  • Sample examination
  • Ioánnina, Epirus, Greece
  • +1 more
Feb 23, 2023

Rehabilitating Vision Loss in Veterans With Age-Related Macular

Not yet recruiting
  • Age-related Macular Degeneration (AMD)
  • Study-specific rehabilitation (SSR) procedures
  • Augusta, Georgia
    Charlie Norwood VA Medical Center, Augusta, GA
Mar 10, 2023

Age-Related Macular Degeneration Trial in Sydney, Melbourne, Tel Aviv (VOY-101)

Recruiting
  • Age-Related Macular Degeneration
  • VOY-101
  • Sydney, New South Wales, Australia
  • +3 more
Oct 17, 2023

Age-Related Macular Degeneration Trial in Toronto (NG101 AAV gene therapy)

Not yet recruiting
  • Age-Related Macular Degeneration
  • NG101 AAV gene therapy
  • Toronto, Ontario, Canada
    Vitreous Retina Macula Specialists of Toronto
Aug 2, 2023

Neovascular Age-related Macular Degeneration Trial (PMC-403)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • (no location specified)
Jul 11, 2023

Neovascular Age-related Macular Degeneration Trial (AXT107 Low Dose, AXT107 Mid Dose, AXT107 High Dose)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • AXT107 Low Dose
  • +2 more
  • (no location specified)
May 5, 2023

Progression of Early Atrophic Lesions

Not yet recruiting
  • Age-Related Macular Degeneration
  • No intervention
  • Salt Lake City, Utah
    University of Utah
Jul 26, 2023

Single Injection of Faricimab for nAMD With Persisting Fluid

Active, not recruiting
  • Neovascular Age-related Macular Degeneration
  • Glostrup, Denmark
    Miklos Schneider
Nov 3, 2023

Age-Related Macular Degeneration Trial in Worldwide (Yellow and red light emitting diode photobiomodulation (Eye Light,

Recruiting
  • Age-Related Macular Degeneration
  • Yellow and red light emitting diode photobiomodulation (Eye Light, Espansione Group, Bologna, Italy)
  • Sham Mask
  • Paris, France
  • +6 more
Sep 14, 2023

Age-Related Macular Degeneration Trial in Rotterdam (Standard lifestyle recommendations + dietary supplementation, Risk

Recruiting
  • Age-Related Macular Degeneration
  • Standard lifestyle recommendations + dietary supplementation
  • +2 more
  • Rotterdam, Netherlands
    Erasmus Medical Center
Dec 19, 2022

Neovascular Age-related Macular Degeneration (nAMD) Trial in Abilene (OCU-10-C-110 for Injection)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration (nAMD)
  • OCU-10-C-110 for Injection
  • Abilene, Texas
    Retina Research Institute of Texas
Jun 6, 2023

Age-related Macular Degeneration Trial in Coimbra (Blood draw and urine collection)

Completed
  • Age-related Macular Degeneration
  • Blood draw and urine collection
  • Coimbra, Portugal
    AIBILI
Jan 6, 2023

Impact of Non-Exudative Type 1 MNV on AMD Progression

Recruiting
  • Age-Related Macular Degeneration
  • Neovascularization, Choroidal
    • Salt Lake City, Utah
      University of Utah
    Nov 15, 2023

    Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (nAMD) Trial (aflibercept 8 mg PFS)

    Not yet recruiting
    • Diabetic Macular Edema (DME)
    • Neovascular Age-Related Macular Degeneration (nAMD)
    • aflibercept 8 mg PFS
    • (no location specified)
    Aug 3, 2023

    Age-Related Macular Degeneration Trial in Malvern, Saint Albans (BBC1501)

    Not yet recruiting
    • Age-Related Macular Degeneration
    • Malvern, Victoria, Australia
    • +1 more
    Apr 5, 2023

    Neovascular Age-related Macular Degeneration Trial in Suzhou (Aflibercept Ophthalmic, IBI302)

    Not yet recruiting
    • Neovascular Age-related Macular Degeneration
    • Aflibercept Ophthalmic
    • IBI302
    • Suzhou, Jiangsu, China
      Innovent Biologics (Suzhou) Co,Ltd.
    Jul 25, 2023

    Neovascular Age-related Macular Degeneration Trial in Shanghai (LX102-C01 Injection)

    Active, not recruiting
    • Neovascular Age-related Macular Degeneration
    • LX102-C01 Injection
    • Shanghai, China
      Shanghai General Hospital, Shanghai Jiao Tong University School
    Apr 14, 2023

    Neovascular Age-related Macular Degeneration (nAMD) Trial (AR-14034 SR implant lower dose, Aflibercept Injection, Sham

    Not yet recruiting
    • Neovascular Age-related Macular Degeneration (nAMD)
    • AR-14034 SR implant lower dose
    • +3 more
    • (no location specified)
    Mar 3, 2023

    Age-Related Macular Degeneration Trial (Active Comparator CT1812, Placebo Comparator)

    Not yet recruiting
    • Age-Related Macular Degeneration
    • Active Comparator CT1812
    • Placebo Comparator
    • (no location specified)
    Jun 5, 2023

    OKKO Health Hyperacuity, Contrast and Colour Game Validation in

    Recruiting
    • Age-Related Macular Degeneration
      • Bristol, United Kingdom
        Bristol
      Nov 16, 2022

      Dry Age-related Macular Degeneration Trial in Rome (Intravitreal injection of CB-PRP)

      Recruiting
      • Dry Age-related Macular Degeneration
      • Intravitreal injection of CB-PRP
      • Rome, Italy
        Fondazione Policlinico Universitario Agostino Gemelli IRCCS
      Jan 23, 2023